Chronic myelogenous leukemia in sickle cell/beta0-thalassemia.
Sallam, Maha M; Alsuliman, Ahmed M; Alahmed, Hejji E; Alabdulaali, Mohammed K.
Indian J Pathol Microbiol
; 2011 Jul-Sept 54(3): 597-598
Artículo en Inglés | IMSEAR | ID: sea-142054
Documentos relacionados
Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
Análisis de la presencia de trisomía 8 en las diferentes fases de leucemia mieloide crónica.
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML).
Chronic Myeloid Leukemia During Pregnancy with Placental Involvement: Case Report and Literature Review.
Measurable residual disease in chronic myeloid leukemia.
Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemia.
Highly precise breakpoint detection of chromosome balanced translocation in chronic myelogenous leukaemia: Case series.
[De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].